- Latest week
- 10 Jul 2026
- Close
- 0.685000
- Fair value
- 0.680333
- Next-week expectancy
- Negative 44.25%
AVCT Chart Pack
Avacta Group Plc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, AVCT fell 7.81%, moving from 0.74 to 0.69. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -0.44 and has softened across the 12-week window. Market Dynamics is -0.51 on the latest week. Next-week expectancy is negative at 44.25% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.69
- 12-Week Change
- -7.81%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 44.25%
- Signal Weeks
- 10 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -0.44
- Market Dynamics
- -0.51
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.69
- 12-Week Change
- -7.81%
- Trend Signal
- Active
- Next-Week Expectancy
- Negative 44.25%
- Signal Weeks
- 10 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- -0.44
- Market Dynamics
- -0.51
Over the latest 12 completed weeks ending 2026-07-10, AVCT fell 7.81%, moving from 0.74 to 0.69. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -0.44 and has softened across the 12-week window. Market Dynamics is -0.51 on the latest week. Next-week expectancy is negative at 44.25% based on similar historical setup states.
Industry Peers
United Kingdom equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| IMM ImmuPharma plc | LSE | 10 Jul 2026 | 0.03 | 0.04 | 0.03 | 0.04 | 16.40% |
| IXI IXICO plc | LSE | 10 Jul 2026 | 0.08 | 0.10 | 0.08 | 0.09 | 12.12% |
| BSFA BSF Enterprise Plc | LSE | 10 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 10.00% |
| SAR Sareum Holdings plc | LSE | 10 Jul 2026 | 0.21 | 0.24 | 0.20 | 0.23 | 9.52% |
| POLB Poolbeg Pharma PLC | LSE | 10 Jul 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 1.45% |
| HEMO Hemogenyx Pharmaceuticals Plc | LSE | 10 Jul 2026 | 7.71 | 8.20 | 7.11 | 7.75 | 0.52% |
| APTA Aptamer Group PLC | LSE | 10 Jul 2026 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00% |
| AREC Arecor Therapeutics plc | LSE | 10 Jul 2026 | 0.64 | 0.65 | 0.62 | 0.64 | 0.00% |
| PYC Physiomics Plc | LSE | 10 Jul 2026 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00% |
| TCF Theracryf Plc | LSE | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| THAT Thalia Therapeutics Plc | LSE | 10 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00% |
| PRTC PureTech Health plc | LSE | 10 Jul 2026 | 120.60 | 124.00 | 115.00 | 120.00 | -0.50% |
| ONT Oxford Nanopore Technologies plc | LSE | 10 Jul 2026 | 121.00 | 128.70 | 111.90 | 120.30 | -0.58% |
| OPTI OptiBiotix Health Plc | LSE | 10 Jul 2026 | 0.06 | 0.07 | 0.06 | 0.06 | -0.78% |
| OXB Oxford Biomedica plc | LSE | 10 Jul 2026 | 617.00 | 623.22 | 581.00 | 611.00 | -0.97% |
| FARN Faron Pharmaceuticals Oy | LSE | 10 Jul 2026 | 0.42 | 0.43 | 0.40 | 0.42 | -1.19% |